Founded
28 Jun 2010

Address

Lilly Ventures
115 W. Washington Street
South Tower 1680
Indianapolis, IN 46204
United States

Open Map


VCID: 30096
    Profile

    Corporate information


    Registration country
    Investment activity status
    Active investor

    Selected investments

    Country Date Notes
    Hemaquest Pharmaceuticals Inc
    United States 1 Apr 2010
    1 Mar 2012
    1 Nov 2007
    Series B
    Active
    Cerulean Pharma Inc
    United States 1 Dec 2011
    1 Nov 2010
    Series D
    Nimbus Discovery LLC
    A computational technology-based drug discovery company.
    United States 28 Jun 2011 Series A
    Sutro Biopharma Inc
    United States 1 Nov 2010 Series C
    Cylene Pharmaceuticals Inc
    Clinical stage private company developing small molecule drugs against newly validated cancer targets.
    United States 1 Jan 2007
    1 Sep 2010
    Series D
    Active
    Receptos Inc []
    United States 1 Nov 2009 Series A
    Avid Radiopharmaceuticals Inc
    United States 1 Jan 2006
    1 May 2007
    1 May 2009
    Series D
    Active
    Fluidigm Corp
    Developer and manufacturer of microfluidic systems for markets in the life science and agricultural biotechnology industries.
    United States 1 Jan 2007 Series E
    Active
    Protagonist Therapeutics Inc
    Biotechnology company dedicated to the discovery of novel peptide and small molecule compounds.
    Australia 1 Sep 2006 Series A
    Active
    Cabrellis Pharmaceuticals Corp
    Development of important therapies for the treatment of cancer
    United States 7 Aug 2006 Series A
    InnoCentive Inc
    United States 1 Feb 2006 Series A
    Active
    Remon Medical Technologies Inc
    Medical device company providing smart, miniature implants.
    United States 1 Sep 2004 Series C
    Viamet Pharmaceuticals Inc
    United States N/A
    Anthera Pharmaceuticals Inc
    United States N/A
    Active

    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.